For research use only. Not for therapeutic Use.
XP-59(Cat No.:I015463)is a potent, selective small molecule inhibitor targeting the c-Myc oncoprotein, a key driver of tumorigenesis. By binding to c-Myc, XP-59 disrupts its interaction with other transcription factors and its function in regulating gene expression, effectively suppressing tumor cell proliferation. This makes it a promising candidate for cancer therapy, particularly for tumors driven by c-Myc overexpression. Preclinical studies indicate that XP-59 can inhibit tumor growth in a variety of cancer models, offering potential as a targeted treatment in precision oncology.
Catalog Number | I015463 |
CAS Number | 890402-73-0 |
Molecular Formula | C₁₅H₁₄N₄O₂ |
Purity | ≥95% |
Target | SARS-CoV |
IUPAC Name | benzotriazol-1-yl 4-(dimethylamino)benzoate |
InChI | InChI=1S/C15H14N4O2/c1-18(2)12-9-7-11(8-10-12)15(20)21-19-14-6-4-3-5-13(14)16-17-19/h3-10H,1-2H3 |
InChIKey | UOITWBIZHQLMTH-UHFFFAOYSA-N |
SMILES | CN(C)C1=CC=C(C=C1)C(=O)ON2C3=CC=CC=C3N=N2 |
Reference | [1]. Verschueren KH, et al,. A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters. Chem Biol. 2008 Jun;15(6):597-606. |